# Unicorn Biotechnologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/unicorn-biotechnologies

- Industry: Biotechnology
- Headquarters: Cambridge, UK
- Website: www.unicornbiotechnologies.com
- Total disclosed funding: $3.2M
- Latest round: Seed (Feb 7, 2022)
- Investors on record: 7

## About

Unicorn Biotechnologies Ltd. is engaged in innovating cell culture automation through advanced robotic systems, enhancing workflows for biotechnology and pharmaceutical industries.Founded in 2020 in Cambridge, UK, Unicorn Biotechnologies Ltd. develops advanced robotic systems focused on automating cell culture processes. The company has successfully completed two funding rounds. In February 2022, Unicorn Biotechnologies raised USD 3.2 mn in a Seed round led by Acequia Capital, with participation from other investors including Marinya Capital and Alumni Ventures Group. The CEO, Jack Reid, leads the company along with co-founders Adam Glen and Jack Reid.Unicorn Bio specializes in the development of general-purpose cell culture robots aiming to automate and enhance cell culture workflows. Their core product offerings include advanced robotic systems designed to standardize and streamline liquid handling processes between cell culture vessels. These robots provide solutions to challenges such as batch failures and labor intensity, serving research institutions, biotechnology companies, and pharmaceutical firms across North America, Europe, and parts of Asia.Unicorn Bio generates revenue primarily through direct sales of robotic systems and associated consumables targeting B2B clients, including universities and commercial laboratories. Their business model includes outright equipment sales and service agreements for ongoing support, with pricing plans tailored to client needs, enhancing potential for recurring revenue through consumable sales and service contracts.In February 2022, Unicorn Biotechnologies raised USD 3.2 mn in Seed funding, which will support the development of new equipment for large-scale food production and accelerate the commercialization of cultivated meat. The company plans to expand into new markets within the biotechnology sector, targeting regions in Europe and Asia by the end of 2024, as part of its growth strategy.

## Funding rounds

- Seed, Feb 7, 2022, $3.2M — SOSV, Acequia Capital, Alumni Ventures Group, Marinya Capital, C3 Ventures, Cult Food Science
- Seed, Mar 24, 2021 — SOSV, HAX

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- HAX — Seed
- Acequia Capital (https://capitalatlas.ai/funds/acequia-capital) — Seed
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Seed
- Marinya Capital — Seed
- C3 Ventures (https://capitalatlas.ai/funds/c3-ventures) — Seed
- Cult Food Science (https://capitalatlas.ai/funds/cult-food-science) — Seed